I agree. There just seems to be no way to make money in the company without a clean start. Even the licensing agreements with UMass are atrocious. The key ingredient is Dr Lanza. I really like the promise of the research and hope this advances beyond our dreams...but as for investing in ACTC...it seems a very risky and tough call.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.